Warning letter
LiquidCapsule Manufacturing, LLC: warning letter of May 15, 2015
FDA warning letter 446062 · Florida District Office
Key facts
| Reference number | 446062 |
|---|---|
| Company | LiquidCapsule Manufacturing, LLC |
| Subject | CGMP/Dietary Supplement/Adulterated/Misbranded |
| Issue date | May 15, 2015 |
| Posted date | Jun 2, 2015 |
| Issuing office | Florida District Office |
| Product type | Food/Cosmetics |
| CFR sections cited | 111.105(a), 111.113(a)(2), 111.205(a), 111.210(g), 111.255(b), 111.255(c), 111.260(d), 111.260(k), 111.260(k)(2), 111.75(a)(1)(i), 111.75(a)(1)(ii), 111.75(a)(2) and 15 more |
| Inspection city | Tampa |
| Inspection ZIP | 33619 |
| Inspection start date | Sep 22, 2014 |
| Letter on fda.gov | web.archive.org |
At a glance
- 10–99 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: